Skip to content

CHINA HEALTH INDUSTRIES HOLDINGS, INC.: 10-Q filed 2024-04-01

What CHINA HEALTH INDUSTRIES HOLDINGS, INC. reported in its quarterly report filed 2024-04-01 (fiscal Q2 2024): 36 published measures, 101 facts as tagged in accession 0001213900-24-028534.

This filing

Form
10-Q (quarterly report)
Filed
2024-04-01
Fiscal period
fiscal Q2 2024
Accession
0001213900-24-028534 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CHINA HEALTH INDUSTRIES HOLDINGS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-12-314,264,870USD
At 2023-06-3045,082,329USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2023-12-31-2,290,278USD
At 2023-09-3038,687,977USD
At 2023-06-3039,109,569USD
At 2022-12-3142,031,182USD
At 2022-09-3039,835,463USD
At 2022-06-3042,802,719USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2023-12-3115,343USD
At 2023-06-3047,246USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2023-10-01 to 2023-12-31-445,557USD92
2023-07-01 to 2023-12-31-627,911USD184
2022-10-01 to 2022-12-31929,303USD92
2022-07-01 to 2022-12-31472,858USD184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-07-01 to 2023-12-31-35,025USD184
2022-07-01 to 2022-12-31512,196USD184

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2023-10-01 to 2023-12-3146USD92
2023-07-01 to 2023-12-3138,346USD184
2022-10-01 to 2022-12-3132,650USD92
2022-07-01 to 2022-12-3132,650USD184

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2023-07-01 to 2023-12-312,853USD184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2023-12-3140,659,996USD
At 2023-06-3041,287,907USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2023-10-01 to 2023-12-3165,539,737shares92
2023-07-01 to 2023-12-3165,539,737shares184
2022-10-01 to 2022-12-3165,539,737shares92
2022-07-01 to 2022-12-3165,539,737shares184

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2023-10-01 to 2023-12-3165,539,737shares92
2023-07-01 to 2023-12-3165,539,737shares184
2022-10-01 to 2022-12-3165,539,737shares92
2022-07-01 to 2022-12-3165,539,737shares184

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2023-10-01 to 2023-12-31-0.0068USD/shares92
2023-07-01 to 2023-12-31-0.0096USD/shares184
2022-10-01 to 2022-12-310.0142USD/shares92
2022-07-01 to 2022-12-310.0072USD/shares184

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2023-10-01 to 2023-12-31-0.0068USD/shares92
2023-07-01 to 2023-12-31-0.0096USD/shares184
2022-10-01 to 2022-12-310.0142USD/shares92
2022-07-01 to 2022-12-310.0072USD/shares184

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2023-12-312,614,478USD
At 2023-06-302,727,170USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2023-10-01 to 2023-12-31-445,555USD92
2023-07-01 to 2023-12-31-629,512USD184
2022-10-01 to 2022-12-31-412,833USD92
2022-07-01 to 2022-12-31-903,556USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2023-12-31249,446USD
At 2023-06-3040,970,292USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2023-10-01 to 2023-12-3142USD92
2023-07-01 to 2023-12-3143USD184

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2023-12-316,555,148USD
At 2023-06-305,972,760USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2023-12-31972,294USD
At 2023-06-30964,775USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2023-10-01 to 2023-12-31445,555USD92
2023-07-01 to 2023-12-31629,512USD184
2022-10-01 to 2022-12-31415,838USD92
2022-07-01 to 2022-12-31906,561USD184

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2023-12-312,392USD
At 2023-06-3040,608USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2022-10-01 to 2022-12-313,005USD92
2022-07-01 to 2022-12-313,005USD184

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2023-10-01 to 2023-12-3146USD92
2023-07-01 to 2023-12-3138,346USD184
2022-10-01 to 2022-12-3129,645USD92
2022-07-01 to 2022-12-3129,645USD184

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2023-10-01 to 2023-12-31362,613USD92
2023-07-01 to 2023-12-31452,056USD184
2022-10-01 to 2022-12-31223,473USD92
2022-07-01 to 2022-12-31558,319USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2023-12-3165,539,737shares
At 2023-06-3065,539,737shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2023-12-3115,343USD
At 2023-06-3047,246USD
At 2022-12-3143,169,488USD
At 2022-06-3044,789,999USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2023-12-31-2,781,639USD
At 2023-06-30-2,745,558USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2023-12-313,980,233USD
At 2023-06-303,771,594USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2023-12-31972,294USD
At 2023-06-30964,775USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2023-10-01 to 2023-12-31-445,557USD92
2023-07-01 to 2023-12-31-627,911USD184
2022-10-01 to 2022-12-31929,303USD92
2022-07-01 to 2022-12-31472,858USD184

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2023-10-01 to 2023-12-31-242,400USD92
2023-07-01 to 2023-12-31-663,992USD184
2022-10-01 to 2022-12-312,195,719USD92
2022-07-01 to 2022-12-31-771,537USD184

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2023-07-01 to 2023-12-31165,534USD184
2022-07-01 to 2022-12-31117,841USD184

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2023-07-01 to 2023-12-3111,923USD184
2022-07-01 to 2022-12-31230,401USD184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2023-10-01 to 2023-12-31-2USD92
2023-07-01 to 2023-12-311,601USD184
2022-10-01 to 2022-12-311,342,136USD92
2022-07-01 to 2022-12-311,376,414USD184

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2023-07-01 to 2023-12-3142USD184

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2023-07-01 to 2023-12-31-21,278USD184

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2023-07-01 to 2023-12-31-38,346USD184
2022-07-01 to 2022-12-31-85,730USD184

Inspect the source

Entity
CHINA HEALTH INDUSTRIES HOLDINGS, INC. / CIK 0001309057
Captured
SEC response SHA-256
93829603b3c881951d34b2b4bb637d2441d1808eaea70ed12e10811c21d923de

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001309057.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))